Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Is a |
Product containing erythromycin in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Is a |
Tretinoin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Erythromycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tretinoin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Is a |
Erythromycin + Tretinoin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has manufactured dose form |
Solution |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has manufactured dose form |
Conventional release cutaneous solution (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Is a |
Product containing tretinoin in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength numerator value |
250 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has basis of strength substance (attribute) |
Tretinoin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has precise active ingredient |
Erythromycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength numerator unit |
mg |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength numerator value |
40 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength numerator unit |
mcg |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has basis of strength substance (attribute) |
Erythromycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has precise active ingredient |
Tretinoin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Is a |
Erythromycin and tretinoin only product in cutaneous dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has precise active ingredient |
Erythromycin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has basis of strength substance (attribute) |
Tretinoin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has basis of strength substance (attribute) |
Erythromycin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has concentration strength numerator unit |
mcg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution |
Has precise active ingredient |
Tretinoin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|